Usefulness of the neutrophil-to-lymphocyte, monocyte-to-lymphocyte and lymphocyte-to-platelet ratios for the prognosis of COVID-19-associated complications
| Autor: | Erika Areli Rosas-Gonzalez, Brenda Santos-González, Christian Omar Ramos-Peñafiel, Eder N. Flores-López, Lucía Hernández-Vázquez, Monica Patricia Bejarano-Rosales, Rosaura Montes de Oca-Yemha, Adolfo Martínez-Tovar, Adrián Santoyo-Sánchez, Carlos Martínez-Murillo, Francisco Galván-Flores, Irma Olarte-Carrillo |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Lymphocyte Gastroenterology Monocytes Cohort Studies 03 medical and health sciences Leukocyte Count 0302 clinical medicine Internal medicine medicine Humans 030212 general & internal medicine Lymphocyte Count Aged Retrospective Studies Mechanical ventilation Aged 80 and over Univariate analysis business.industry Platelet Count Monocyte fungi Area under the curve Type 2 Diabetes Mellitus COVID-19 Retrospective cohort study General Medicine Middle Aged Prognosis medicine.anatomical_structure Female business Cohort study |
| Zdroj: | Gaceta medica de Mexico. 156(5) |
| ISSN: | 0016-3813 |
| Popis: | Various biomarkers based on blood counts have been useful for the prognosis of patients critically ill with COVID-19.To describe the usefulness of the neutrophil-to-lymphocyte (NLR), monocyte-to-lymphocyte (MLR) and lymphocyte-to-platelet (LPR) ratios for the prognosis of mortality and ventilatory support requirement for COVID-19.Retrospective cohort of clinical records of patients with COVID-19 who required hospital care.One-hundred and -twenty-five cases were analyzed; mean age was 51 years, and 60 % were of the male gender; 21.6 % had type 2 diabetes mellitus, and 18.4 % had hypertension. Mean leukocyte count was 9.5 x 10NLR and MLR are useful for predicting mortality in patients with COVID-19.Diversos biomarcadores basados en conteos sanguíneos han sido de utilidad para el pronóstico de los pacientes en estado crítico por COVID-19.Describir la utilidad de los índices neutrófilo/linfocito (INL), monocito/linfocito (IML) y linfocito/plaqueta (IPL) para el pronóstico de la mortalidad y necesidad de soporte ventilatorio por COVID-19.Cohorte retrospectiva de registros clínicos de pacientes con COVID-19 que requirieron atención hospitalaria.Se analizaron 125 casos, la edad media fue de 51 años y 60 %, del sexo masculino; 21.6 % padecía diabetes mellitus tipo 2 y 18.4 %, hipertensión. La media de leucocitos fue 9.5 × 10INL e IML son de utilidad para predecir la mortalidad en pacientes con COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|